 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 05/30/2023 |
$2.02 |
$2.14 |
$2.01 |
$2.08 |
43.30K | | 05/31/2023 |
$2.05 |
$2.14 |
$2.04 |
$2.11 |
27.10K | | 06/01/2023 |
$2.09 |
$2.14 |
$2.05 |
$2.10 |
52.90K | | 06/02/2023 |
$2.10 |
$2.11 |
$2.01 |
$2.11 |
43.20K | | 06/05/2023 |
$2.05 |
$2.11 |
$2.03 |
$2.08 |
12.80K |
|
|
| ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. | |
|
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on May 30, 2023, ABIO opened at $2.02, traded as high as $2.14 and as low as $2.01, and closed at $2.08. Trading volume was a total of 43.30K shares. On May 31, 2023, ABIO opened at $2.05, traded as high as $2.14 and as low as $2.04, and closed at $2.11. Trading volume was a total of 27.10K shares. On June 01, 2023, ABIO opened at $2.09, traded as high as $2.14 and as low as $2.05, and closed at $2.10. Trading volume was a total of 52.90K shares. On June 02, 2023, ABIO opened at $2.10, traded as high as $2.11 and as low as $2.01, and closed at $2.11. Trading volume was a total of 43.20K shares. On June 05, 2023, ABIO opened at $2.05, traded as high as $2.11 and as low as $2.03, and closed at $2.08. Trading volume was a total of 12.80K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/07/2013 |
|
| End date: |
06/05/2023 |
|
| Start price/share: |
$190.26 |
|
| End price/share: |
$2.08 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-98.91% |
|
| Average Annual Total Return: |
-36.34% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$109.31 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 05/30/2023 | $2.08 | | 05/31/2023 | $2.11 | | 06/01/2023 | $2.10 | | 06/02/2023 | $2.11 | | 06/05/2023 | $2.08 |
|
|
Free ABIO Email Alerts:
